Cognetivity Neurosciences Ltd. (CGNSF) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Healthcare Information Services secteur d'activité. Le siège social de l'entreprise est situé à Vancouver, BC, Canada. Le PDG actuel est Sina Habibi.
CGNSF a date d'introduction en bourse 2021-01-08, 2,500 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $8.96K.
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
